Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: Relation to insulin action

Diabetologia

Volumn 43, Issue 3, 2000, Pages 304-311

  Loviscach, M ^a   Rehman, N ^a   Carter, L ^a   Mudaliar, S ^a   Mohadeen, P ^a   Ciaraldi, T P ^a   Veerkamp, J H ^b   Henry, R R ^a,c  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c VA S Diego Healthcare Syst ^*  (United States)

Author keywords

Adipose tissue; Human; Insulin resistance; Obesity; PPAR ; PPAR ; PPAR ; Protein; Skeletal muscle; Type II diabetes

Indexed keywords

BIGUANIDE; INSULIN; ORAL ANTIDIABETIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; SULFONYLUREA;

ADIPOSE TISSUE; ADULT; ARTICLE; BIOPSY; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKELETAL MUSCLE; TISSUE DISTRIBUTION; WESTERN BLOTTING;

EID: 0034064359     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050048     Document Type: Article

References (41)

1. 1. Schoonjans K, Staels B, Auwerx J (1996) The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302: 93-109
2. 2. Auverx J (1999) PPAR gamma, the ultimate thrifty gene. Diabetologia 42: 1033-1049
3. 3. Su J, Simmons CJ, Wisely B, Ellis B, Winegar DA (1998) Monitoring of PPAR alpha protein expression in human tissue by the use of PPAR alpha-specific MAbs. Hybridoma 17: 47-53
4. 4. Staels B, Dallongeville J, Auverx J, Schoonjans K, Leitersdorf E, Fruchart J (1998) Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98: 2088-2093
5. 5. Staels B, Auverx J (1998) Regulation of apo A-1 gene expression by fibrates. Atherosclerosis 137: [Suppl] S19-S23
6. 6. Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, Bastin J, Gonzalez FJ (1998) A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated Receptor α-deficient mice. J Clin Invest 102: 1083-1091
7. 7. Meertens LM, Miyata KS, Cechetto JD, Rachubinski RA, Capone JP (1998) A mitochondrial ketogenic enzyme regulates its gene expression by association with the nuclear hormone receptor PPARα. EMBO J 17: 6972-6978
8. 8. Motojima K, Passilly P, Peters JM, Gonzalez FJ, Latruffe N (1998) Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ activators in a tissue-and inducer-specific manner. J Biol Chem 273: 16710-16714
9. 9. Shalev A, Siegrist-Kaiser CA, Yen PM et al. (1996) The peroxisome proliferator activated receptor α is a phosphoprotein: regulation by insulin. Endocrinology 137:4499-4502
10. 10. Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137: 354-366
11. 11. Saltiel AR, Olefsky JM (1996) Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45: 1661-1669
12. 12. Elbrecht A, Chen Y, Cullinan CA et al. (1996) Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem Biophys Res Commun 224: 431-437
13. 13. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83: 803-812
14. 14. Krey G, Braissant O, L'Horset F et al. (1997) Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 11: 779-791
15. 15. Forman BM, Chen J, Evans RM (1996) The peroxisome proliferator-activated receptors: ligands and activators. Ann NY Acad Sci 804: 266-275
16. 16. Pearson SL, Cawthorne MA, Clapham JC et al. (1996) The thiazolidinedione insulin sensitiser, BRL 49653, increases the expression of PPAR-gamma and aP2 in adipose tissue of high-fat-fed rats. Biochem Biophys Res Commun 229: 752-757
17. 17. Berger J, Bailey P, Biswas C et al. (1996) Thiazolidinediones produce a conformational change in peroxisome proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137: 4189-4195
18. 18. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270: 12953-12956
19. 19. Reginato MJ, Bailey ST, Krakow SL et al. (1998) A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor γ-activating properties. J Biol Chem 273: 32679-32684
20. 20. Fajas L, Auboeuf D, Raspe E et al. (1997) The organization, promoter analysis, and expression of the human PPAR gamma gene. J Biol Chem 272: 18779-18789
21. 21. Vidal-Puig AJ, Considine RV, Jimenez-Linan M et al. (1997) Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99: 2416-2422
22. 22. Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE, Henry RR (1997) PPAR-gamma gene expression is elevated in skeletal muscle of obese and type 2 diabetic subjects. Diabetes 46: 1230-1234
23. 23. Vidal-Puig A, Jimenez-Linan M, Lowell BB et al. (1996) Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 97: 2553-2561
24. 24. Lefebvre AM, Laville M, Vega N et al. (1998) Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47: 98-103
25. 25. Zierath JR, Ryder JW, Doebber T et al. (1998) Role of skeletal muscle in thiazolidinedione insulin sensitiser (PPAR gamma agonist) action. Endocrinology 193: 5034-5041
26. 26. Yost TJ, Eckel RH (1992) Regional similarities in the metabolic regulation of adipose tissue lipoprotein lipase. Metabolism 41: 33-36
27. 27. Thorburn AW, Gumbiner B, Bulacan F, Brechtel G, Henry RR (1991) Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J Clin Invest 87: 489-495
28. 28. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Diabetes Care 20: 1183-1197
29. 29. Henry RR, Abrams L, Nikoulina S, Ciaraldi TP (1995) Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Diabetes 44: 936-946
30. 30. Burnette WN (1981) "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A Anal Biochem 112: 195-203
31. 31. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein-dye binding. Anal Biochem 71: 248-254
32. 32. Fajas L, Auboef D, Raspe E et al. (1997) The organization, promoter analysis, and expression of the human PPARγ gene. J Biol Chem 272: 18779-18789
33. 33. Paulussen RJ, Geelen MJH, Beynen AC, Veerkamp JH (1989) Immunochemical quantitation of fatty-acid-binding proteins. Tissue and intracellular distribution, postnatal development and influence of physiological conditions on rat heart and liver FABP. Biochim Biophys Acta 1001: 201-209
34. 34. Cox RD, Garner I, Buckingham ME (1990) Transcriptional regulation of actin and myosin genes during differentiation of a mouse muscle cell line. Differentiation 43: 183-191
35. 35. Zhou YT, Wang ZW, Higa M, Newgard CB, Unger R (1999) Reversing adipocyte differentiation: implications for treatment of obesity. Proc Natl Acad Sci USA 96: 2391-2395
36. 36. Brun RP, Spiegelman BM (1997) PPAR gamma and the molecular control of adipogenesis. J Endocrinol 155: 217-218
37. 37. Spiegelman BM (1998) PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47: 507-514
38. 38. Rieusset J, Andreelli F, Auboeuf D et al. (1999) Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-γ in human adipocytes. Diabetes 48: 699-705
39. 39. Kruszynska YT, Mukherjee R, Jow L, Dana S, Paterniti JR, Olefsky JM (1998) Skeletal muscle peroxisome proliferator-activated receptor-γ expression in obesity and non-insulin-dependent diabetes mellitus. J Clin Invest 101: 543-548
40. 40. Crettaz M, Muller-Wieland D, Kahn CR (1988) Transcriptional and posttranscriptional regulation of tyrosine aminotransferase by insulin in rat hepatoma cells. Biochemistry 27: 495-500
41. 41. Berger J, Leibowitz MD, Doebber TW et al. (1999) Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects. J Biol Chem 274: 6718-6725